GeneDx
Colton Frazer is a highly skilled professional in health economics and outcomes research, currently serving as a Senior Health Economics and Outcomes Research Scientist at GeneDx since March 2025. Prior to this role, Colton held positions as Senior Manager of Health Economics and Outcomes Research at Vertex Pharmaceuticals and as an Adjunct Faculty member at the University of Health Sciences and Pharmacy in St. Louis. From July 2022 to May 2024, Colton was a Health Economics and Outcomes Research Fellow at Agios Pharmaceuticals while also teaching as an Adjunct Faculty member at Massachusetts College of Pharmacy and Health Sciences. Colton's earlier experiences include roles as a Hospital Pharmacy Intern at Barnes-Jewish Hospital and various pharmacy technician positions. Colton's academic credentials include a Doctor of Pharmacy (PharmD) and a Bachelor of Pharmaceutical Sciences from the University of Health Sciences and Pharmacy in St. Louis, alongside an MBA with an emphasis in Health Economics from the University of Missouri-Saint Louis.
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.